Indigo Carmine, ampoules 0.4%, 5ml, 10pcs

Composition

Active ingredient:

Indigo Carmine (in terms of dry matter) – 4 mg,

Auxiliary substances:

Sodium formaldehyde sulfoxylate dihydrate-0.5 mg,

Sodium hydrocitrate sesquihydrate-1.0 mg,

Water for injection – up to 1,0 ml

Pharmacological action

Pharmacotherapeutic group: Diagnostic medium Pharmacodynamics :

Diagnostic tool from the dye group.

Application is based on the ability of Indigo Carmine to be rapidly excreted unchanged in the urine without causing impaired renal function.

Pharmacokinetics:

Indigo Carmine is mainly excreted by the kidneys, retaining its blue color. Elimination begins within 10 minutes after use. The elimination half-life is about 4-5 minutes.

Indications

Examination of the excretory function of the kidneys, including the renal pelvis and ureters.

For visual detection of violations of the integrity of the cavity organs and the length of fistulous passages.

Contraindications

Hypersensitivity to Indigo Carmine or any other component of the drug side effects on the use of Indigo Carmine in the anamnesis pregnancy and lactation children under 18 years of age.

With caution:

Kidney failure.

Side effects

Allergic reactions idiosyncrasy increased blood pressure.

Interaction

Pharmacologically incompatible with other medicinal products with the exception of 09% sodium chloride solution.

How to take, course of use and dosage

Intravenously intravenously into the fistula passages.

Before use, the drug is heated to 37 °C.

Intravenously slowly – 5-20 ml of a solution of 4 mg / ml. If the solution cannot be administered intravenously, it is administered intramuscularly in a volume of 20 ml (while the rate of appearance of the drug in the urine decreases). Urinary excretion of Indigo Carmine is monitored using a cystoscope. With normal renal function, the dye begins to be released from the ureters in 2-3 minutes, the maximum excretion is noted in 6-8 minutes, and ends in 1-15 hours. In patients with impaired renal function, excretion is less intense and more delayed.

An undiluted solution of 4 mg/ml is introduced intracavitarily or into fistulous passages, or 5 ml of a solution of 4 mg/ml (1 ampoule) is diluted immediately before use in 400 ml of 09% sodium chloride solution.

Special instructions

Some patients may experience an increase in blood pressure.

Influence on the ability to drive vehicles and mechanisms:

The drug is used only in a hospital setting.

Form of production

Solution for intravenous use

Storage conditions

Store in a dark place at a temperature not exceeding 25 °C.

Keep out of the reach of children.

Shelf

life is 2 years.

Do not use after the expiration date indicated on the package.

Active ingredient

Indigo Carmine

Conditions of release from pharmacies

By prescription

Dosage form

solution for injection